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A new miniaturized protein and peptide sequenator 
has been constructed which uses  gas phase reagents at 
the coupling and cleavage  steps of the Edman degra- 
dation. The sample is embedded in a  matrix  of Poly- 
brene  dried onto a porous glass fiber disc located in a 
small cartridge-style reaction cell. The protein or  pep- 
tide, though not covalently attached to the support, is 
essentially immobile throughout the degradative cycle, 
since only relatively apolar, liquid phase solvents  pass 
through the cell. This instrument can give useful se- 
quence data on as little as 5 pmol or protein, can 
perform extended sequence runs (>30 residues) on sub- 
nanomole quantities of proteins purified by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis, 
and can sequence hydrophobic peptides to completion. 
The sequenator is characterized by a high repetitive 
yield during the degradation, low reagent consumption, 
low maintenance requirements, and a degradative cy- 
cle time of only 50 min using a complete double cleav- 
age program. 
Since  its  introduction  in 1967, the use of automated  Edman 
degradation in the  spinning  cup  sequenator  has been the  most 
widely used method for determining  the  primary  structure of 
polypeptides (1). For  many  years,  the  major  limitations f the 
technique were the  large  amounts of sample  required (10 to 
several  hundred nmol) and difficulty  in  sequencing short (less 
than 50 amino  acids) peptides. These  problems were  mainly 
due  to  sample loss during  the  repeated  extractions with or- 
ganic solvents used to  remove nonvolatile reagents  and by- 
products  from  the  sample fiim. Early  attempts  to minimize 
sample loss included  the use of more volatile  coupling  buffers 
(2, 3 ) ,  reduction in the volume of extraction  solvents (4, 5), 
and  the  addition of various  nonprotein  carriers  to  the  cup  to 
add  mass  and  stability  to  the  sample film ( 3 ) .  However, the 
major breakthrough came with the introduction of a poly- 
meric quaternary  ammonium  salt,  Polybrene,  to spinning cup 
sequencing technology (6, 7). This  substance effectively an- 
chors small quantities of both  proteins  and  peptides in the  cup 
and allows sequencing of even  short  hydrophobic  peptides  to 
completion. By combining the use of Polybrene with more 
extensive  purification of reagents  and solvents, improvements 
in spinning  cup  sequenator design, and analysis of >PhNCS’- 
derivatives by  reverse phase  HPLC, two of us (M. W. H. and 
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L. E. H.) have previously obtained extended NHn-terminal 
sequence  information  on  subnanomole  quantities of a variety 
of peptides  and  proteins (8,9). 
The solid phase sequencing system of Laursen (IO), wherein 
the  protein  or  peptide is covalently attached  to a derivatized 
glass or  polystyrene  support, was  developed  in  parallel  with 
the  spinning  cup  system  and provides another answer to  the 
problem of extractive  sample loss. However, the  major limi- 
tations of this  technique  are  that  it is rarely possible to  achieve 
quantitative  attachment of sample  to  the  support  phase,  an- 
other set of reagents and solvents is required for covalent 
sample attachment, and gaps appear in the amino acid se- 
quence  where  attachment  has occurred. The  identity of these 
attached residues cannot be determined directly. 
In  the  present  report, we describe a new type of sequenator 
which, based partly on previous work (11-14), employs gas 
phase reagents instead of liquid phase reagents a t  critical 
points in the  Edman  degradation.  This modification means a 
miniaturized cartridge-type  reaction cell can replace the  spin- 
ning cup assembly and  the  elaborate  hardware associated with 
it.  The  advantages of this new miniaturized  gas-liquid solid 
phase  system  are  as follows: high  sensitivity  sequencing,  very 
low reagent  and  solvent  consumption, a much  shorter degra- 
dative cycle, and low maintenance  and  running costs. Unlike 
the  Laursen solid phase sequencing system, which also em- 
ploys  a cartridge-style  reaction cell, the  present  system  does 
not require covalent attachment of sample to the support 
phase. 
SEQUENATOR DESIGN 
The gas-liquid  solid phase  sequenator  has  certain  features in com- 
mon with the liquid phase spinning cup sequenator described by 
Hunkapiller and Hood (8, 9, 15)’ and some critical differences, as 
shown  in  the  schematic (Fig. 1). 
The similarities  include the following: the use of argon,  delivered 
through a series of filters, to pressurize the reagent and solvent 
reservoirs; similar argon pressure-regulation manifold,  reservoir  pres- 
surizing  valves, and reservoir-venting  manifold;  similar  reagent/sol- 
vent reservoirs, some of which are modified to deliver vapor as 
opposed to liquid; the use of zero-holdup, pneumatically actuated 
diaphragm valves for delivery of reagents, solvents, and argon; and 
control of valve function by means of a  solid state programmer. 
The  major differences are  summarized  as follows: the  replacement 
of the  cup  and drive unit by a cartridge assembly which houses a 
miniature glass reaction  chamber  (internal volume, -0.050 ml)  and 
the presentation of the polypeptide sample in this chamber on a 
porous glass  fiber disc. The  cartridge is mounted  in  an  insulated oven 
equipped with heating  and cooling elements for programmed  temper- 
ature control. 
The pneumatically actuated diaphragm valves have been minia- 
turized to reduce their internal volume to  one-tenth of that in  the 
spinning cup system. These valves also control the vacuum to the 
cartridge  and  the  >PhNCS conversion  flask. The large electromag- 
netic  vacuum valves that  are used in  the  spinning  cup  instrument  are 
not required. The reservoirs and various delivery valve blocks are 
mounted in the  vertical  plane  directly  above  and below the  reaction 
cartridge as appropriate  to minimize the  length of connecting tubing. 
’ M. W. Hunkapiller  and L. E. Hood, submitted for publication. 
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FIG. 1. Schematic  diagram of gas- Liquid solid phase  sequenator. 
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FIG. 2. Enlarged detail of reaction chamber. 
The automatic conversion flask and fraction collector are miniatur- 
ized, and  the vacuum pump and liquid nitrogen trap also are corre- 
spondingly smaller. 
Reaction Cartridge-The cartridge is constructed from two pieces 
of Pyrex glass rod (1 inch diameter X 1 inch long) with finely ground 
vacuum-flat surfaces a t  both ends (Wilmad Glass Company, Buena, 
NJ).  Each piece of glass is ultrasonically machined (L. C. Miller Co., 
Monterey Park, CA) so that it has a 0.020-inch diameter central 
capillary flared-wt  to give a conical recess at one end. An important 
feature is that  the hole and recess in each piece of glass are mutually 
concentric to within 0.001 inch. The recessed ends of the two pieces 
of glass are clamped together in a  metal cylinder to form a central 
recess sufficient to hold the glass fiber disc (GF/C Glass Microfibre 
chamber. The conical cavity in the upper piece of glass has  a small 
Filter,  Whatman Ltd., England) on which the protein or peptide is 
supported. Clamped between the two pieces of glass is a fibrous 
porous Teflon disc (Zitex filter membrane, extra-coarse grade, Chem- 
plast Inc., Wayne, NJ). This Teflon disc physically supports the glass 
fiber disc and is crushed between the abutting glass surfaces to give 
F 
WINDOW 
4 
TO VACUUM, 
FLASK, OR WASTE 
FIG. 3. Cartridge assembly. A,  aluminum top fitting; E ,  Teflon 
tubing; C, aluminum cap; D, Teflon washer; E ,  keyed aluminum 
washer; F, 304 stainless steel cartridge body; G, Pyrex glass  rod; H ,  
aluminum locking ring; I ,  aluminum mounting base; J, Kel-F bottom 
fitting; K,  Kel-F valve block. 
a vacuum seal. Enlarged detail of this arrangement is shown in Fig.  2. 
A general diagram of the cartridge assembly and  its relationship to 
the upper valve block (argon, reagent, and solvent delivery) and the 
lower  valve  block (vacuum, delivery to flask, and delivery to waste) 
is shown in Fig. 3. Critical features of the cartridge design are that 
alignment of the 0.020-inch diameter hole running from the upper 
valve  block to  the lower  valve  block is reproducibly maintained and 
that  the whole system is vacuum tight. These points are particularly 
important, since the top fitting ( A )  is disconnected and the cartridge 
is removed from the mounting base (n each time a sample is loaded. 
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7992 Gas-Liquid Solid Phase Sequenator 
TABLE I
Comparison of the  reagent and solaent consumption per cycle of Edman  degradation  in a spinning  cup (see Footnote 2) and a gas-liquid 
solid Dhase seauenator 
Reagentholvent (spinning cup) Volume Reagent/solvent (gas-liquid) Volume 
R1: 
R2: 
R3: 
R4: 
s1: 
s2: 
s3: 
s4: 
5% phenylisothiocyanate in n-heptane 
Quadrol/trifluoroacetic acid, pH 9.0, in 
water/propanol (43) 
Heptafluorobutyric acid, 0.01% dithiothre- 
itol 
25% trifluoroacetic acid in water, 0.01% 
dithiothreitol 
Benzene 
Ethylacetate, 0.05% acetic acid, 0.002% di- 
thiothreitol 
1-Chlorobutane, 0.001% dithiothreitol 
Acetonitrile, 0.001% dithiothreitol 
ml 
0.4 
0.7 
0.5 
0.3 
7 
16 
7 
4 
15% phenylisothiocyanate in n-heptane 
25% trimethylamine in water 
Trifluoroacetic acid, 0.01% dithiothreitol 
" Excluding I-ml flask rinse. 
The upper  aluminum washer ( E )  is keyed into the cartridge wall so 
that when the  cap IC) is tightened, the two pieces of glass (G) do not 
rotate. The washer also serves to precisely align the upper fitting (A)  
relative to  the central capillary. The upper  and lower Teflon washers 
(D) protect the top and bottom glass surfaces. A vacuum seal is 
achieved at  the  top fitting (A)  by a  direct flanged Teflon tubing  fit on 
the glass surface. A vacuum seal at  the bottom of the cartridge is 
achieved by pressurized contact between the glass surface and a Kel- 
F fitting (4, and between this Kel-F  fitting  and the Kel-F valve block 
( K )  . 
Delivery Values-The delivery valves are of the basic pneumati- 
cally actuated diaphragm type described by Whittmann-Liebold (16) 
and Hunkapiller and Hood (15).' However, in  this case, significant 
design modifications have been made. The most notable change is 
that  the valves have been substantially miniaturized. The internal 
valve capillaries are 0.020 inch in diameter as opposed to 0.060 inch, 
and the length, depth, and width of the Kel-F valve blocks are 
reduced. The net effect is a  reduction of over IO-fold  in the internal 
volume accessible to liquid. The reduction in size has resulted in 
closer hole-spacing in the valve block. This  has necessitated a  thinner 
and  smoother diaphragm to ensure good sealing properties. Appro- 
priately, for these valves, the original 0.010-inch thick Teflon mem- 
brane has been replaced by a 0.005-inch thick FEP-Teflon  membrane. 
Reagent and Solvent Reseruoirs-The reservoirs are smaller than 
those used  in the spinning cup  sequenator in order to be compatible 
with the much lower consumption and the need to maintain  a fairly 
rapid turnover of reagents and solvents. Since reagent 2 is trimeth- 
ylamine/water vapor instead of Quadrol buffer, and reagent 3 is 
trifluoracetic acid vapor instead of liquid heptafluorabutyric acid, 
delivery lines in the reservoirs for reagent 2 and reagent 3 are 
appropriately modified (see Fig. 1) to allow vapor rather  than liquid 
delivery. An adjustable flow meter (Gilmont Instruments,  Great Neck, 
NY)  fitted with relatively inert perfluoroelastomer O-rings (Kalrez, 
E. I. du Pont de Nemours & Co., Wilmington, DE) is connected 
between the reservoir and  the delivery valve block and  is used to 
control  and monitor the gas flow rates for reagent 2 and reagent 3. 
Fraction Collector and Conversion Flask-The fraction collector 
is a vacuum tight  unit with a carousel designed to house one hundred 
300-pl tubes. The conversion flask, similar in design to  that described 
by Hunkapiller and Hood (15)' and Wittmann-Liebold et  al. (17). has 
been miniaturized to  an internal volume of about 2.0  ml. This reduc- 
tion ensures efficient transfer of sample and washing of the flask walls 
with small volumes of solvent. 
Reagents and Soluents-The reagents  and  solvents are listed in 
Table I along with their  approximate  per cycle consumption. Great 
emphasis has been placed on the purity of reagents  and solvents used 
for the Edman degradation. Details of appropriate distillation proce- 
dures for all reagents and solvents except trimethylamine will be 
given  elsewhere.' Trimethylamine, which replaces Quadrol buffer as 
reagent 2, was obtained from Eastman Organic Chemicals (Rochester, 
25% trifluoroacetic acid in water, 0.01% dithiothre- 
itol 
Benzene 
Ethylacetate, 0.05% acetic acid, 0.002% dithiothre- 
I-Chlorobutane, 0.001% dithiothreitol 
Acetonitrile, 0.001% dithiothreitol 
itol 
ml 
0.05 
5 cc/min argon flow 
5 cc/min argon flow 
0.05 
1.1 
2.7 
1.2 
0.3' 
NY) and is purified by refluxing with phthallic anhydride  (Matheson, 
Coleman, and Bell, Nonvood, OH) at  5 "C for 1-2  h. This procedure 
is followed  by distillation through  a glass column filled with phthallic 
anhydride  into  a receiving flask cooled in a dry ice/acetone bath.  The 
trimethylamine is stored  under argon as a 25% (v/v) solution in water 
at -20 "C. 
SEQUENATOR OPERATION 
Sample Loading-The procedure for loading protein or peptide 
into the cartridge is as follows. The top fitting (Fig. 3, A )  is discon- 
nected  and the cartridge is removed from the mounting base (0 by 
unscrewing the locking ring (H). The cap  (C) is removed and the two 
glass blocks (C) are withdrawn from the cartridge body ( E 3  for 
cleaning. The used porous Teflon disc is replaced with a new one. 
The used glass fiber disc is discarded and replaced by a new disc (12- 
mm diameter)  cut from Whatman GF/C sheet. An aqueous solution 
(0.025 ml) of Polybrene (60 mg/ml)  and glycylglycine (1 pmol/ml) is 
spotted  onto  the disc and dried under vacuum. After reassembly of 
the cartridge, the sequenator program is run for four cycles. Following 
this, the cartridge is once again disassembled and the upper glass 
block holding the GF/C disc is removed. Without removing the disc 
from its recess in the glass block, the solution of protein is spotted 
onto the disc and dried under vacuum. If the sample volume is greater 
than 0.025 ml, it is spotted and dried in aliquots. The cartridge is then 
reassembled and the sequence run is commenced. 
generally similar to  that described by Hunkapiller and Hood (8, 15)' 
Program-The sequenator program is listed in Table 11" and is 
for their modified spinning cup  sequenator. However, since the pres- 
ent instrument uses a miniaturized cartridge system and gas phase 
reagents, there  are several features  worth noting. 1) Only sufficient 
phenylisothiocyanate solution to completely wet the, glass fiber disc 
is delivered (-20 pl). The heptane is removed by briefly flushing the 
cartridge with argon. 2) The coupling stage is effected by slowly 
bleeding trimethylamine/water vapor through the cartridge to waste. 
Likewise, cleavage is effected by slowly bleeding trifluoroacetic acid 
vapor through the cartridge to waste. 3) Line flush is used to pressur- 
ize the cartridge with argon after  a vacuum step,  or, with the cartridge 
waste valve open, to flush the delivery valve block, lines, and cartridge 
with argon. 4) The miniaturized conversion flask has two argon 
supplies: line flush, which flushes the flask delivery valve block and 
A portion of this paper (Table 11) is presented in miniprint at  the 
end of this paper. Miniprint is easily read with the aid of a standard 
magnifying  glass. Full size photocopies are available from the  Journal 
of Biological Chemistry, 9650 Rockville Pike, Bethesda, Md. 20814. 
Request  Document No. 81M970, cite author(s),  and include a check 
for $1.60 per set of photocopies. Full size photocopies are also included 
in the microfilm edition of the  Journal  that is available from Waverly 
Press. 
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Gas-Liquid Solid Phase Sequenator 7993 
lines and pressurizes the flask; and flask argon, which delivers argon 
into the bottom of the flask to aid drying and agitation of fluids. 5) 
The conversion flask, in addition to the vapor-vent valve, has a liquid 
waste outlet (see Fig. l), so that the flask can be thoroughly rinsed 
with solvent during each cycle (steps 65 and 66). 6) To confine the 
sample to the lower tip of the miniaturized flask and also perform 
efficient extraction, the amino acid anilinothiazolinone is extracted 
from the glass fiber filter with several small volumes of chlorobutane 
(steps 77-83). Continuous drying of the flask contents is necessary 
nmol 
nmol 
nmol 
nmol 
0 IO 20 30 40 50 60 70 80 90 
FIG. 4. Yields of >PhNCS valine, histidine, leucine, and glu- 
tamic acid derivatives from an NHz-terminal amino acid se- 
quence analysis of 10 nmol of sperm whale apomyoglobin. 
Aliquots (40%) from each cycle were analyzed by HPLC as described 
under “Results.” HPLC peak heights were converted to nanomoles 
for each derivative using values from a standard mixture of >PhNCS- 
derivatives, and the yields were normalized to 100% injection. 
AVERAGE 
R.Y.= 97.5 
p mol 
p mol 
AVERAGE 
R.Y. = 93.9 % 
FIG. 5. Sequenator repetitive cycle yield with various 
amounts of sperm whale apomyoglobin. Semilogarithmic plots 
of >PhNCS valine (A) yields (cycles 1, 10, 13, 17, and 21) and 
>PhNCS leucine (m) yields (cycles 2, 9, 11, 29, and 32) uersus 
sequenator cycle are shown for analysis of 10 nmol, 1 nmol, 100 pmol, 
and 10 pmol of protein. The repetitive yield (R. Y.) at each cycle was 
calculated from the slopes of the linear-least-squares-fitted straight 
lines for the plots of >PhNCS yields. 
2.5 
I I I I I 
0 5 IO 15 20 
CYCLE 
5 
FIG. 6. Yields of >PhNCS valine, leucine, and alanine deriv- 
atives from an NHZ-terminal amino acid sequence analysis of 
10 pmol of sperm whale apomyoglobin. Yields were calculated as 
described in the legend to Fig. 4. 
5.0 5nmo~ load 
(-5/Lg) 
26 26 
3 
4 
5 u 
26 26 26 
“t 
2 6 26 26 
CYCLE 
FIG. 7. Yields of >PhNCS-derivatives from NHz-terminal 
amino acid sequence analyses of 5 nmol, 500 pmol, and 70 
pmol angiotensin II (sequence: H-Asp-Arg-Val-Tyr-Ile-His- 
Pro-Phe-OH). Yields were calculated as described in the legend to 
Fig. 4. 
and is effected by flushing the flask with argon during these steps in 
order to minimize the time between extraction from the disc and 
addition of reagent 4 to the flask. 
In the present program, the cartridge is maintained at 42 “C. The 
basic program incorporates a single coupling stage with two deliveries 
of phenylisothiocyanate and two complete cleavage stages. The amino 
acid anilinothiazolinone released by the shorter first cleavage stage 
(step 71) is extracted and directed to the conversion flask, and the 
derivative extracted after the second cleavage is directed to waste. 
This procedure reduces exposure of the more labile amino acid 
derivatives to strong anhydrous acid, since most of the derivative is 
released during the first cleavage, yet maintains an adequate overall 
cleavage time. In most cases, a sequence run is initiated with a double 
coupling. This is performed by completing the first degradative cycle 
with the reagent 3 valve switched off. 
Protein and Peptide Preparation-Human angiotensin II was 
obtained from Pierce Chemical Co. (Rockford, IL). Carboxymethyl- 
ated insulin B chain was obtained from Mann Research Laboratories 
(New York, NY). [Ala3, “‘ISomatostatin was synthesized by J. Rivier 
and R. Guillemin (Salk Institute, San Diego, CA). Neuropeptide B 
from Aplysia calijorrzica (18) was a gift from J. Yeakley and F. 
Strumwasser (Division of Biology, California Institute of Technol- 
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7994 Gas-Liquid Solid Phase Sequenator 
ogy). Dynorphin was purified and supplied by A. Goldstein (Addiction 
Research Foundation, Palo Alto,  CA). Sperm whale myoglobin 
(Sigma) was purified and converted to the apoprotein according to 
the method of Edman and Begg (1) or obtained from Beckman 
Instruments  (Palo Alto, CA). Larval cuticle proteins of Drosophila 
melanogaster purified by isoelectric focusing on polyacrylamide gels 
containing urea were supplied by M. Snyder and N.  Davidson (Divi- 
sion of Chemistry and Chemical Engineering, California Institute of 
Technology) and D. Silvert and J .  Fristrom (Department of Genetics, 
University of California, Berkeley, CA). The 22,000-dalton membrane 
phosphoprotein from A. californica was purified by SDS-polyacryl- 
amide gel electrophoresis and supplied by  L. Kaczmarek, K. Jennings, 
and F. Strumwasser (Division of Biology, California Institute of 
Technology). The a and p chains of human histocompatibility antigen 
HLA-DR were purified and supplied by L. Walker and  R. Reisfeld 
(Department of Molecular Immunology, Scripps Clinic and Research 
Foundation, La Jolla, CA). Human erythropoietin was purified and 
supplied by E. Goldwasser (Department of Biochemistry, The Uni- 
versity of Chicago, Chicago, IL). Human melanoma cell-surface anti- 
gen supplied by J. Brown (Division of Tumor Immunology, Fred 
Hutchison Cancer Research Center, Seattle, WA) was purified by 
SDS-polyacrylamide gel electrophoresis. 
STANDARD CYCLE 1 
J6.P 
CYCLE 2 
..I> - 
I CYCLE 7 
I . ~ ~ ~ ~ ' ~ " ~ ~ ~ ~ " ~ " . . " ~ ' ' ~ ' ~ ~ ~ ' ' " ' ' ' ~ ' ' ~ ~ ~  
I 3 5 7 D , I  1 1 ,  1 5 7 D ) I  1 3 1  3 5 7 I I  13 
" I H I I E B  
FIG. 8. HPLC traces  from an NHz-terminal amino acid se- 
quence analysis of 50 pmol of human angiotensin 11. The 
absorbance meter of the HPLC detector was set a t  0.005 absorbance 
units full scale. The chromatograms were recorded on a Hewlett- 
Packard series 3354 laboratory automation computer and the chro- 
matographic solvent background from a blank injection (10 p1 of 
acetonitrile,) was subtracted by the computer to give the  traces shown 
in the figure. The order of elution of zPhNCS-derivatives (12.5 pmol 
of each) in the standard mixture (upper left corner) is Asn, Ser, Thr, 
Gln, Gly, Ala, His, AspOMe, GluOMe, Tyr, Val, Pro, Met, Ile, Leu, 
Phe, Trp, Lys, and Arg. Ten-p1 aliquots, representing 40% of each 
sample, were injected. The positions of the rPhNCS-derivatives 
assigned in the traces for cycles 1 through 6 are indicated by the 
arrows and the three-letter  amino acid designations. The positions 
of the expected >PhNCS-derivatives for cycles 7 and 8 are indicated 
in a similar manner, although they are not assignable in this experi- 
ment. 
>PhNCS-derivative Analysis-Sequenator fractions were ana- 
lyzed by reverse phase  HPLC using Altex Ultrasphere Cyano columns 
(Beckman Instruments). Details of the procedure have been described 
previously (19). 
RESULTS 
Sperm  whale  apomyoglobin  was  sequenced  using  various 
programs  and at several  levels of sample  loading in order to 
test the efficiency of the gas-liquid  solid  phase  sequenator  in 
performing the Edman  degradation. The fiist 90 amino  acid 
residues  were  identified  from a single  sequenator run with a 
10-nmol load of protein (Fig. 4). The yields of individual 
>PhNCS-derivatives are similar t o  those reported previously 
(8); those of authentic >PhNCS serine  and  >PhNCS  threo- 
nine, two of the most  troublesome, are 15 and 30%, respec- 
tively. The  reproducibility of the background of >PhNCS- 
derivatives  (Fig. 4) afforded  by the automatic  conversion 
system allows accurate residue assignment even late in the 
run when the signal-to-background  ratio  is  low.  Based  upon 
quantitation of the amount of protein  loaded on the cartridge 
disc  by  amino  acid  analysis of a companion  aliquot, the yields 
of >PhNCS valine  and  >PhNCS  leucine at cycles 1 and 2, 
respectively,  were in excess of 90%. 
The repetitive cycle yield for runs with myoglobin loads 
ranging from 10 nmol  to 5 pmol  varied from 98% (10 nmol)  to 
96% (500 pmol) to 94% (50 pmol) to 92% (5 pmol)  (Fig. 5) .  The 
drop in repetitive  yield as the sample  load is decreased  most 
likely  reflects the effect of sample  washout  during the solvent 
extractions  and/or  trace  levels of oxidants in the sequenator 
system.  Trace  levels of oxidants are suspected,  because  only 
in the lowest  sample  load (5 pmol)  was  identification of serine 
and  tryptophan  residues,  both of which are very  sensitive  to 
oxidative destruction, impossible. Even with these effects, 
partial  sequence  data  to  residue 22 was obtained  on the 5- 
pmol  myoglobin run (Fig. 6). 
Human  antiogensin I1 was  used to test the ability of the  
new  sequenator  to  handle  short,  relatively  hydrophobic  pep- 
tides. The yields of >PhNCS-derivatives  for runs with  angio- 
TABLE 111 
Polypeptides analyzed with the gas-Liquid solid phase sequenator 
Residues 
identified/ Amount 
total resi- 
dues 
Sample 
Pmol Ilg 
Angiotensin 8/8 500 0.5 
Angiotensin 6/8 50  0.05 
Somatostatin 14/14 1,400 2.0 
Insulin, B chain 30/30 300 1.0 
Neuropeptide B from Aplysia 31/34 500 2.0 
Dynorphin 14/17 20 0.04 
Myoglobin  90/153 10,OOO 165 
Myoglobin  22/153 5 0.08 
Larval cuticle protein 1 from Dro- 55/166  850 
Larval cuticle protein 3 from Dro- 36/96 900 9 
22,000-dalton membrane phospho- 23/200  15 0.3 
Human histocompatibility antigen 49/300 700 23 
Human histocompatibility antigen 39/240  500  1  
Human erythropoietin' 28/150 100 1.6 
Human melanoma cell surface anti- 13/850 60 5.5 
sophila" 
sophila" 
protein from Aplysia' 
HLA-DR, a chain 
HLA-DR, p chain 
genb 
a Purified by isoelectric focusing  in polyacrylamide gels containing 
Electrophoretically eluted from Coomassie blue-stained, SDS- 
60% carbohydrate by weight. 
urea. 
polyacrylamide gel. 
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Gas-Liquid  Solid  Phase  Sequenator 7995 
tensin loads ranging from 5 nmol to 50 pmol are shown  in  Fig. 
7. The complete sequence of the octapeptide could  be deter- 
mined using 5 m o l  and 500 pmol of sample, and all but  the 
last 2 residues (proline and phenylalanine) could be deter- 
mined using 50 pmol. The HPLC traces from a 50-pmol 
angiotensin run are shown in Fig. 8. Very little extraneous 254 
nm absorbing material appears in the chromatograms. Those 
artifacts that  are present, mainly a small peak eluting just 
after  >PhNCS methionine derivative, do not seriously inter- 
fere with identification. Interference with identification of  low 
levels of >PhNCS  aspartic acid and >PhNCS glutamic acid 
derivative, which can be obscured by the reduced and oxidized 
forms of dithiothreitol, is avoided by methylating the acidic 
side chains with a 1 N methanolic HC1 solution prior to HPLC 
analysis (20). 
Selected proteins and peptides that have been  analyzed  in 
the new sequenator are listed in’ Table 111. Several of these 
polypeptides presented potential sequencing problems that, in 
fact, did not interfere seriously with sequenator performance. 
These problems (see “Discussion”) included the presence of 
numerous proline residues in the sequence and the contami- 
nation of the samples by residue from the techniques used  in 
their preparation, which included SDS-polyacrylamide gel 
electrophoresis and isoelectric focusing. 
DISCUSSION 
Sample Immobilization-The chief feature that distin- 
guishes the new gas-liquid solid phase sequenator described 
in this report from previously described sequenators is the 
method by which the sample is  immobilized during the cou- 
pling and cleavage stages of the Edman chemistry. In the 
classic Edman spinning cup sequenator, the sample is held in 
solution in a  thin film of liquid on the interior wall of the cup 
(1). In the Laursen solid phase sequenator, the sample, cova- 
lently attached  to  a solid support,  is immersed in a  stream of 
liquid reagent (10). In the new sequenator, the sample is 
embedded in a matrix of Polybrene into which the combina- 
tion of liquid and gaseous reagents diffuse to carry out the 
Edman chemistry. 
Since, in the  Edman spinning cup sequenator, the sample is 
freely soluble in the reagents and would  be  removed  from the 
reaction cup by a continuous stream of reagents, an elaborate 
system for metering in precise aliquots of reagents every 
degradation cycle  is required. The aliquots must reproducibly 
and precisely  cover the sample film every cycle or the reac- 
tions may not go to completion. In pract,ice, the required 
reproducibility is not easily maintained. Moreover, the re- 
quirements for an open reaction cup lead to an inefficient 
solvent extraction system for removal of nonvolatile reagent 
components, reaction byproducts, and amino acid anilino- 
thiazolinones cleaved from the polypeptide. A thin liquid film 
must be maintained by mechanically rotating the cup at 
relatively high speeds, and this process is subject to interfer- 
ence by imperfections in the interior of the cup and corrosion 
of the drive bearings on the spinning cup assembly. 
Many of these problems are absent in the Laursen solid 
phase sequenator. However, a new difficulty that in practice 
is often more difficult to overcome than those discussed above 
is introduced. Since the sample is exposed to continuous 
streams of liquid reagents that would tend to quickly  remove 
it from the reaction cell, it must be held in place by covalent 
attachment  to a solid support such as derivatized polystyrene 
or glass beads contained in the cell. Covalent attachment 
requires the introduction of another set(s) of chemical re- 
agents and steps, is often quite inefficient (less than 20% 
attachment is common) even under seemingly ideal circum- 
stances, and is particularly difficult with samples that contain 
very little polypeptide and relatively large amounts of extra- 
neous material remaining from the peptide purification pro- 
cedures. In any case, the peptide is lost once tbe sequencing 
progresses inward from its  NH2 terminus to  the last  attach- 
ment site. Also, the identity of those amino acid residues 
directly involved in the covalent linkage cannot be determined 
directly. 
In  the new gas-liquid solid phase sequenator, the sample is 
never exposed to liquids in which it is appreciably soluble. 
Therefore, neither  an open, spinning cup type reaction cham- 
ber nor covalent attachment  to  a solid support is necessary to 
retain  the sample in the reaction vessel. The primary require- 
ment for preventing sample loss is a means of protecting the 
polypeptide from being dislodged by mechanical shearing 
forces as the extraction solvents (in which the sample is 
generally quite insoluble) flow past it. This requirement is 
met by embedding the sample in a thin film of Polybrene 
dispersed on a porous glass disc. The disc, comprised of a 
mesh of overlapping fibers, is held transversely across the 
reaction chamber. This  structure possesses a relatively high 
total surface area (hence allowing a very thin film) with a 
minimum dimension in the direction of fluid flow. The Poly- 
brene film is readily permeable to  the reagent vapors and to 
the extraction solvents, so that flowing gases  or liquids can 
diffuse into  and  out of the film to carry out chemical reactions 
or extractions without mechanically disturbing the sample. 
The Polybrene forms a cohesive fim that adsorbs strongly to 
the porous glass  disc and is insoluble in the extracting solvents. 
Component Miniaturization-An important characteristic 
of the reaction cartridge built around the sample support disc 
is the ease with which the sample containment area can be 
miniaturized. This, along with the simple flow-through nature 
of the cartridge assembly, allows the reagent and solvent 
consumption to be reduced to one-tenth  or less of that used  in 
commercial instruments. This  has several benefits worth no- 
ting. The first is a significant reduction in operating costs. A 
second is the increased practicality of providing the required 
amounts of ultrapure reagents and solvents, an important 
consideration since many of the commercially available chem- 
icals require additional purification to provide the desired 
level of purity. Yet a  third advantage is the increase in speed 
with which samples can be sequenced. This results from the 
decreased time required for mass transfer in the miniaturized 
system and from the very rapid changeover  from  one sample 
to  another. Cycle time is only 45-55 min, and sample reloading 
(including cartridge cleanup and Polybrene precycling) is only 
3-4 h. A final benefit and the one that is perhaps most 
important, is that lower reagent and solvent usage per cycle 
results in a reduced accumulation of impurities accompanying 
the >PhNCS-derivative samples that  are analyzed by HPLC. 
The low HPLC backgrounds shown  in  Fig. 8 attest  to  the low 
background  level of the sequenator, and this miniaturization 
of artifacts is essential to sequencing at ultramicro levels. 
Efficiency of Edman Chemistry-The  efficiency  with  which 
the new sequenator performs the Edman chemistry, as judged 
by its repetitive cycle yield, is at least as good as  the best 
available spinning cup sequenators and better  than the Laur- 
sen-type solid phase instruments. Average repetitive yields of 
98% are obtainable with as  little as 10 nmol of protein, and 
92% cycle  yields can be obtained with only 5 pmol  of protein 
(Fig. 5). Sequencing efficiency  also  is  high  for peptide analysis, 
with complete sequencing of small to medium peptides pos- 
sible with subnanomole quantities. 
Several factors contribute to  this high  efficiency.  One is the 
thoroughness with which the sample cartridge can be cleansed 
with the extracting solvents. Another is the protection of the 
sample from removal from the reaction chamber. Other fac- 
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7996 Gas-Liquid Solid  Phase  Sequenator 
tors include the thoroughness with which the entire reaction 
system can be protected from leaks and cross-contamination, 
purged with argon, and evacuated. Also, the coupling base 
used in this system, trimethylamine, is  very  easily purified by 
distillation, whereas Quadrol and other buffers  used in clas- 
sical sequenators are difficult to purify and are prone to 
contain impurities, such as aldehydes, which  block the Edman 
chemistry. Further, since the Edman reactions can  proceed to 
completion rapidly at 42 "C (rather  than  the usual 55 "C),  the 
acid-catalyzed splitting of the polypeptide chain that gener- 
ates background >PhNCS-derivative signals and reduces re- 
petitive yield is lessened (1, 21). The miniaturization even 
increases the efficiency of the analysis of the >PhNCS-deriv- 
ative fractions. The >PhNCS-derivatives generated in the 
automatic conversion flask are transferred directly into  the 
300-pJ conical tubes used in the autosampler for the HPLC 
system. This saves time, avoids sample loss, reduces chances 
of sample contamination, and improves quantitation. 
Versatility in Sequencing a Variety of Samples-In order 
for the new gas-liquid  solid phase sequenator to be a general 
purpose instrument, it was designed to handle as wide a 
variety of polypeptides as possible. A representative listing of 
the samples that have been analyzed with this instrument 
illustrates its versatility (Table 111). Proteins can be  analyzed 
using less than 10 pmol (0.2 pg) of sample; peptides can be 
sequenced with less than 100 pmol (0.1 pg) of sample. Both 
hydrophobic peptides and proteins, including integral mem- 
brane proteins, can be sequenced. Proteins purified by SDS- 
polyacrylamide gel electrophoresis and by electrofocusing in 
polyacrylamide gels can be analyzed after the proteins are 
electrophoretically eluted from the gels. Polypeptides, such as 
Aplysia neuropeptide B (18), that contain several proline 
residues followed by amino acid residues with bulky side 
chains (arginine, phenylalanine, tyrosine) also  pose no serious 
problems if the cleavage time is  doubled to minimize overlap 
due to incomplete reaction (22). 
Future Developments in  Protein Sequencing-The sensi- 
tivity of the new sequenator is such that further increases in 
sensitivity of amino acid sequencing by this technique will 
require parallel improvements in analysis of the >PhNCS (or 
similar) derivatives and in purification techniques for submi- 
crogram quantities of proteins. If the sequencing sensitivity 
can be increased to  the 1 pmol level, which seems within the 
range of the present sequenator,  then proteins isolated from 
analytical two-dimensional polyacrylamide gel electrophoresis 
(23) can be screened by NHz-terminal sequence analysis for 
identification. Because of the enormous resolving power of 
this separation method, partial characterization of even  very 
rarely expressed proteins would  be  possible. This  partial se- 
quence analysis can then be  used to synthesize nucleic  acid 
primers for cDNA cloning of the mRNA from which the 
proteins are translated (24). Such techniques have already 
been used to clone such rare message  genes as those coding 
for the interferons (25) and human histocompatibility antigens 
(26). Once the genes are cloned, then  structural analysis of 
the proteins can be completed by rapid DNA sequence anal- 
ysis. In this way, partial protein microsequencing,  gene  clon- 
ing, and DNA sequence analysis could  be  used to characterize 
a wide variety of biologically and biomedically important 
proteins even  when they are present in trace amounts. 
This combination of methods for protein and gene struc- 
tural analysis is particularly important when studying multi- 
gene families such as immunoglobulins, histocompatibility 
antigens, and interferons. The task of correlating which  gene 
corresponds to which gene product will require structural 
analyses of both the proteins and the genes in multigene 
families. Thus in studying multigene families, the phenotypic 
or protein sequence analyses will  be as  important  as the DNA 
sequence analyses. 
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